GE HealthCare Technologies Inc. (NASDAQ:GEHC) Holdings Decreased by Nuveen Asset Management LLC

Nuveen Asset Management LLC lowered its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 0.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 922,880 shares of the company's stock after selling 4,998 shares during the quarter. Nuveen Asset Management LLC owned about 0.20% of GE HealthCare Technologies worth $72,151,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. JPMorgan Chase & Co. boosted its stake in GE HealthCare Technologies by 29.8% in the third quarter. JPMorgan Chase & Co. now owns 2,233,603 shares of the company's stock worth $209,624,000 after purchasing an additional 512,778 shares in the last quarter. Park Avenue Securities LLC boosted its position in GE HealthCare Technologies by 9.7% during the fourth quarter. Park Avenue Securities LLC now owns 4,450 shares of the company's stock valued at $348,000 after purchasing an additional 392 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its position in shares of GE HealthCare Technologies by 26.0% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,304 shares of the company's stock valued at $102,000 after purchasing an additional 269 shares during the period. Certified Advisory Corp boosted its position in shares of GE HealthCare Technologies by 16.8% in the fourth quarter. Certified Advisory Corp now owns 5,421 shares of the company's stock valued at $424,000 after acquiring an additional 779 shares during the period. Finally, Avanza Fonder AB bought a new position in shares of GE HealthCare Technologies in the fourth quarter worth $2,303,000. 82.06% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on GEHC. Morgan Stanley cut their target price on shares of GE HealthCare Technologies from $86.00 to $78.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. BTIG Research set a $95.00 target price on GE HealthCare Technologies and gave the stock a "buy" rating in a research report on Monday, April 14th. Piper Sandler decreased their price target on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Citigroup decreased their price objective on GE HealthCare Technologies from $105.00 to $86.00 and set a "buy" rating on the stock in a report on Wednesday, April 30th. Finally, UBS Group raised GE HealthCare Technologies from a "sell" rating to a "neutral" rating and cut their price objective for the company from $74.00 to $73.00 in a research report on Monday, May 5th. Three research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $88.27.

GE HealthCare Technologies Stock Down 1.7%

Shares of GEHC stock traded down $1.25 during trading on Tuesday, reaching $71.85. The company's stock had a trading volume of 3,268,213 shares, compared to its average volume of 3,422,895. The stock's 50-day moving average price is $70.87 and its 200 day moving average price is $79.96. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The company has a market capitalization of $32.90 billion, a price-to-earnings ratio of 16.59, a P/E/G ratio of 3.19 and a beta of 1.21.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The company reported $1.01 EPS for the quarter, beating analysts' consensus estimates of $0.91 by $0.10. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $4.78 billion for the quarter, compared to analyst estimates of $4.66 billion. During the same period in the previous year, the business posted $0.90 earnings per share. GE HealthCare Technologies's quarterly revenue was up 2.7% on a year-over-year basis. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Friday, April 25th were paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.19%. The ex-dividend date was Friday, April 25th. GE HealthCare Technologies's payout ratio is 2.95%.

GE HealthCare Technologies declared that its board has approved a stock repurchase plan on Wednesday, April 30th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 3.1% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's board of directors believes its stock is undervalued.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.